Health Care/Hospital
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA
- LatAm-FINGERS Study Findings Confirm and Expand U.S. POINTER Trial Results - - Show Structured Dementia Risk Reduction Strategies Adaptable Across Cultures - Key Takeaways * The LatAm-FINGERS study shows lifestyle interventions adapted across Latin American cultures, health systems and commu...
2026-07-13 12:01
2929
Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB
SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...
2026-07-13 12:00
3744
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
* 873 employees volunteered more than 3,600 hours across 7 Asian markets to support local communities. * Employees partnered with 21 community organizations, positively impacting more than 4,300 people through initiatives focused on patient support, inclusion, education and environmental su...
2026-07-13 10:00
2818
Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases
SHANGHAI, July 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI),and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking pharmaceutical ...
2026-07-13 08:30
3836
AIA ANNOUNCES WINNERS OF THE AIA HEALTHIEST SCHOOLS COMPETITION
HONG KONG, July 13, 2026 /PRNewswire/ -- AIA Group Limited ("AIA" or the "Group") is proud to unveil the winners of the fourth annualAIA Healthiest Schools Competition, a flagship initiative of the AIA Healthiest Schools programme ("AHS") which empowers students aged five to 16 to turn healthy l...
2026-07-13 08:00
2685
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026
FORMER ELITE SOCCER PLAYERS SHOW EVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFE Key Takeaways * New research provides insights into brain health among former elite professional soccer players during midlife. * Former players reported high levels of depression, anxiety, and subjective difficult...
2026-07-12 12:01
3670
Smartee S22: Incorporating GS MART Technology into Occlusal Reconstructive Therapy in Prosthodontics
SHENZHEN, China, July 10, 2026 /PRNewswire/ -- Smartee Denti-Technology has announced the launch of S22: GS MART (Mandibular Repositioning Technology) for Occlusal Reconstruction in Prosthodontic Dentistry, expanding the clinical application of its GS MART into prosthodontic dentistry. The projec...
2026-07-10 18:07
5371
Puncture Robotic Showcases AI-Powered Hair Restoration Innovation at WCHR 2026
SEOUL, South Korea, July 10, 2026 /PRNewswire/ -- Artificial intelligence is rapidly reshaping medical aesthetics, and hair restoration is undergoing a significant technological transformation. At the 14th World Congress for Hair Research (WCHR 2026), Puncture Robotic attracted international atte...
2026-07-10 17:47
4664
Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch Held in Beijing
When Healthcare Meets AI: A New Era of Ecosystem-wide Innovation Is Accelerating BEIJING, July 10, 2026 /PRNewswire/ -- On July 4, the Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch was held in Beijing. Jointly organized by Liaowang Finance, under ...
2026-07-10 17:04
5542
Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC
NANJING, China, July 10, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license application (BLA) for Opamtistomig (LBL-024, a PD-L1/4-1BB bispecific antibody) as monotherapy for the treatment of adva...
2026-07-10 16:53
5170
POMDOCTOR LIMITED Continues to Advance AI-Enabled Chronic Disease Management Strategy Amid Growing Demand for Predictive Healthcare
GUANGZHOU, China, July 9, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today highlighted its continued efforts in building an AI-powered chronic disea...
2026-07-09 20:00
5276
Professor Gang Shen's Orthodontic Team Publishes Third Consecutive Paper in the Journal of Aligner Orthodontics
SHANGHAI, July 8, 2026 /PRNewswire/ -- Professor Gang Shen, Chief GS R&D Scientist of Smartee Denti-Technology and Chief Orthodontist at Taikang Dental, together with his orthodontic team, has published a new researcharticle titled " Pathological Mandibular Retrusion: Causality and Orthodontic Int...
2026-07-09 17:55
4296
InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation
NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical results of ifebemtinib (IN10018), a highly selective...
2026-07-09 17:28
4614
WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy
SHIJIAZHUANG, China, July 9, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG8 drug substance manufacturing facility located in Hebei has successfully passed the Pre-License Inspection (PL...
2026-07-09 15:31
4550
Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine
HANGZHOU, China, July 8, 2026 /PRNewswire/ -- On July 8, the study of Betta's ensartinib as postoperative adjuvant therapy for patients with stage IB–IIIB (T3N2M0) ALK-positive non-small cell lung cancer (NSCLC), known as the ELEVATE study,was published online in full in The New England Journal o...
2026-07-09 10:16
3484
Morinaga Milk Industry Co., Ltd. Recognized for Child Nutrition and Community Well-Being Initiative at Asia Responsible Enterprise Awards 2026
KUALA LUMPUR, Malaysia, July 9, 2026 /PRNewswire/ -- Morinaga Milk Industry Co., Ltd. has been recognized under the Social Empowerment category at the Asia Responsible Enterprise Awards (AREA) 2026, organized by Enterprise Asia, with PR Newswire as the Official News Release Distribution Partner. ...
2026-07-09 10:00
5071
HanchorBio Tests Broader Ambitions for HCB101 Through InxMed Partnership
Taiwan-listed biotech looks to expand the value of its lead oncology asset through combination research with late-stage cancer drug resistance specialist InxMed. TAIPEI and SHANGHAI and SAN FRANCISCO, July 8, 2026 /PRNewswire/ -- HanchorBio, Inc. (TWSE: 7827) is taking another step to broaden th...
2026-07-09 09:13
3689
Allianz Partners Appoints Carsten Staat as Regional Managing Director for Asia Pacific, Middle East & Africa
SINGAPORE, July 9, 2026 /PRNewswire/ -- Allianz Partners, a world leader in B2B2C insurance and assistance, today announced the appointment of Carsten Staat as Regional Managing Director for Asia Pacific, Middle East & Africa (APAC & MEA), effective 1 August 2026. Carsten will report to Jacob Fue...
2026-07-09 09:00
4469
Insilico Medicine Releases Positive Profit Alert for the First Half of 2026
CAMBRIDGE, Mass., July 8, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" or the "Company", HKEX: 3696), a generative artificial intelligence (AI)-driven clinical-stage biotech company, today delivered a positive profit alert for the six months ended June 30, 2026 ("First Half of 2026"). The s...
2026-07-09 08:30
4086
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on June 30 in...
2026-07-09 08:00
4750
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 263 media titles]
2026-10-05 11:51Most Read
RoboParty Unveils RP1, a High-Performance Full-Stack Open-Source Humanoid Robot at IROS
2026-10-04 00:56
10671
Nuix Neo Generative AI Framework
2026-10-08 08:02
9102
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8125
